-
Porton Pharma Solutions Partners with Guangzhou Geneseed Biotech to Advance circRNA Therapies
•
Porton Pharma Solutions Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into a strategic partnership with Guangzhou Geneseed Biotech Co., Ltd., a company specializing in circular RNA (circRNA)-focused CRDMO services. This collaboration aims to expedite the development of innovative circRNA therapies, enhancing technical innovation, clinical translation, and…
-
Porton Pharma Solutions Invests €50 Million in Slovenian R&D Expansion
•
China-based Contract Development and Manufacturing Organization (CDMO) Porton Pharma Solutions Ltd has inaugurated a new research and development (R&D) center in Mengeš, Slovenia, marking a significant step in the company’s global expansion strategy. The investment, totaling €50 million ($54.1 million), encompasses the acquisition and comprehensive renovation of the facility, which…
